摘要
目的 对重组的刚地弓形虫RH株主要表面抗原 1(SAG1)原核表达载体SAG1/pET 32c ,在大肠杆菌中诱导表达产物进行亲和纯化 β免疫反应性检测评价。 方法 接种含SAG1/pET 32c的BL2 1单菌落至LB肉汤中 ,1∶10 0稀释转种后用 1mmol/L终浓度的IPTG诱导表达 ,表达产物用Ni2 + 螯合柱亲和纯化 ,并用免疫印迹技术对纯化的融合蛋白进行免疫反应性检测 ,用重组融合蛋白对弓形虫病 5 2份阳性和 4 0份阴性血清进行初步检测。结果 SAG1/pET 32c在原核系统中 ,经诱导表达出约 370 0 0大小的融合蛋白 ,并以包涵体的形式存在 ;通过Ni2 + 亲和柱纯化可获得SAG1重组融合蛋白。免疫印迹试验表明 ,重组SAG1融合蛋白能被弓形虫阳性血清特异性的识别。初步检测表明 ,阳性和阴性符合率分别为 81% (42 /5 2 )和 95 % (38/40 )。结论 SAG1在原核系统获得高效表达 ,亲和纯化的rSAG1具有较强的免疫反应性 ,对弓形虫病的免疫诊断具有潜在应用价值 ,也为人用或兽用的弓形虫病免疫诊断试剂盒研制奠定了基础。
Objective To express the major surface antigen gene SAG1 in E. coli, purify the recombinant fusion protein SAG1 and evaluate its immunoresponse. Methods A single colony of E. coli BL21 containing the plasmid SAG1/pET-32c was inoculated LB broth, then diluted 1∶100 into 1000 ml LB broth and induced with 1mmol/L IPTG. The recombinant SAG1 was purified with Ni 2+ chelating HiTrap HP column. Its immunoresponse was evaluated with Western-blot. Fifty-two IgG-positive and forty IgG-negtive human sera were tested with rSAG1.Results The recombinant SAG1 protein about 37 kDa was expressed in E.coli as inclusion body. rSAG1 was prepared with Ni 2+ column purification. The result of Western-blot showed that rSAG1 could be recognized by positive serum of Toxoplasmosis. The positive correspondence rate and negtive correspondence rate of rSAG1-ELISA was 81% (42/52) and 95% (38/40) respectively. Conclusions High-level expression of SAG1 was achieved in E. coli, the purified rSAG1 had strong immunoresponse. It indicated that rSAG1 had a potential value for immunodiagnosis of Toxoplasmosis.
出处
《中华检验医学杂志》
CAS
CSCD
北大核心
2004年第2期107-109,共3页
Chinese Journal of Laboratory Medicine
基金
江苏省寄生虫病重点学科江苏省寄生虫分子生物学实验室开放课题资助项目 (WK2 0 0 2 15 )